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Hydrolytic enzymes [acid phosphatase, /?-glucuronidase, p-D-N-acetyl glucosaminidase @-D-NAGA), 
lysozyme and angiotensin-converting enzyme (ACE)] are the major constituents of alveolar macrophages 
(AM). These enzymes play a crucial role in the pathogenesis of interstitial lung diseases. 
Cell-associated activity of several enzymes in alveolar macrophages obtained from control subjects (n=5) 
and patients suffering five representative types of interstitial pulmonary diseases [sarcoidosis (n = lo), extrinsic 
allergic alveolitis (n=5), idiopathic pulmonary fibrosis (n=5), neoplastic infiltration of the lung (n= 5) and 
Pneumocystis carinii pneumonia (n=5)] were evaluated. Cells were obtained by bronchoalveolar lavage and 
isolated by Ficoll-Hypaque gradient. Enzymatic activity was assessed by standardized tests. 
Bronchoalveolar lavage (BAL) lymphocyte counts were significantly elevated in the patients with active 
sarcoidosis (median: 57%), allergic extrinsic alveolitis (median: 51%) and neoplasic infiltration (median: 31%) 
as compared with the other groups, whereas BAL neutrophil and eosinophil counts were significantly elevated 
in the patients with idiopathic pulmonary fibrosis (neutrophil median: 29%; eosinophil median: 3%). The 
highest alveolar macrophage enzymatic activities were obtained in the active sarcoidosis group (median ACE: 
23.38 PKat 10 ~ 6 AM; median lysozyme: 8.64 nKat 10 - 6 AM; median P-glucuronidase: 324.22 U 10 - 6 
AM; median acid phosphatase: 0.78 nKat 10 ~ 6 AM; median /3-D-NAGA: 1.85 nKat 10 - 6 AM) which 
was significantly greater than in the control group (median ACE: 6.69pKat lop6 AM; median 
lysozyme: 1.95 nKat 10 - 6AM; median P-glucuronidase: 39.88 U 10 - 6 AM; median acid phosphatase: 
0.38 nKat 10 - 6 AM; median P-D-NAGA: 044 nKat 10 - 6 AM). However, intracellular lysosomal enzymatic 
activities of alveolar macrophages from patients with allergic extrinsic alveolitis, a disease in which the degree 
of alveolar macrophage activation is maximal, were similar to those of the control group. 
These findings demonstrated a different pattern of expression of alveolar macrophage’s hydrolytic enzymes 
in lymphocytic diffuse pulmonary interstitial disease. In sarcoidotic patients, hydrolytic enzymes were 
increased whereas in allergic extrinsic alveolitis, hydrolytic enzyme activities were similar to control groups. 
Indirect data suggest that the release of lysosomal enzymes by alveolar macrophages during allergic extrinsic 
alveolitis may be a factor involved in the pulmonary lesions appearing in this disease. 
Introduction 
The pulmonary interstitial-alveolar region is con- 
tinuously attacked by antigens from the exterior and 
from the pulmonary circulation. Alveolar macro- 
phages play a crucial role in the induction and 
resolution of inflammatory pulmonary injury. In 
order to participate adequately in the inflammatory 
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response, alveolar macrophages release large num- 
bers of soluble mediators (i.e. hydrolytic enzymes, 
oxygen free radicals, cytokines, arachidonic acid 
metabolites) which can injure the lung parenchyma. 
Hydrolytic enzymes are the major constituents of 
alveolar macrophages and have been shown to be 
involved in many aspects of the inflammatory pulmo- 
nary response, in addition to their better known role 
in bactericidal processes (1). Although it is known 
that in most diffuse interstitial pulmonary diseases 
there is recruitment and activation of macrophages 
(2), no systematic study has been conducted on the 
catalytic activity of hydrolases in these diseases. 
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The aim of this study was to evaluate the cell- 
associated activity of the enzymes: acid phosphatase 
(E.C. 3.1.3.2) P-glucuronidase (E.C. 3.2.1.31), P-D- 
N-acetyl glucosaminidase (E.C. 3.2.1.30), lysozyme 
(E.C. 3.2.1.17) and angiotensin-converting enzyme 
(E.C. 3.4.15.1) in alveolar macrophages obtained 
from patients suffering from interstitial pulmonary 
diseases. 
Methods 
PATIENTS AND CONTROLS 
A total of 35 subjects were subjected to broncho- 
alveolar lavage (BAL) for diagnostic purposes. All 
were examined clinically and a basic complementary 
study was also carried out, covering the essential 
analytical parameters, such as simple chest X-ray. 
None of the subjects smoked and none had been 
treated for at least 2 months prior to study. All 
were informed of the technical aspects of the pro- 
cedure and written consent was obtained prior to the 
bronchoalveolar lavage. 
Subjects were divided into six groups: 
Group 1 (control) 
This group consisted of five subjects (four men and 
one woman; mean age 47 years) selected according 
to the criteria of Reynolds et al. (3). All of them 
displayed unexplained dry cough. No bronchoscopic 
anomalies were observed in the pulmonary area in 
which the BAL was performed. Normal subjects were 
not included in this study for ethical reasons. 
Group 2 (sarcoidosis) 
This group consisted of 10 patients (seven women 
and three men; mean age 49 years). The diagnosis of 
sarcoidosis was based on a compatible clinical pic- 
ture, the presence of non-caseating granulomas of the 
liver, lymphatic ganglia and/or pulmonary tissue and 
exclusion of other diseases (4). Patients with pulmo- 
nary sarcoidosis were classified into two subgroups. 
Six patients had active sarcoidosis according to three 
criteria (bronchoalveolar lymphocytes >28%, an 
increased serum angiotensin-converting enzyme con- 
centration and a pathological uptake of 67Ga in 
pulmonary parenchyma) and the other four patients 
had inactive sarcoidosis. 
Group 3 (allergic extrinsic alveolitis) 
These five subjects (four men and one woman; 
mean age 54 years) fulfilled the criteria of Salvaggio 
and Karr for this syndrome (5). The final diagnoses 
were bird fancier’s lung in two cases, farmer’s lung in 
two cases and plasterer’s lung in one case. Four 
extrinsic allergic alveolitis patients had an acute form 
of the disease (less than 1 week of evolution) and the 
other patient had a subacute form. 
Group 4 (idiopathic pulmonary jibrosis) 
This group consisted of five patients (three women 
and two men; mean age 67 years). The diagnosis 
of idiopathic pulmonary fibrosis was based on the 
following (6): (a) pulmonary biopsy specimen dem- 
onstrating fibrosis of the alveolar wall with inflam- 
matory changes in the absence of granulomas; (b) 
interstitial infiltrates demonstrated by chest radio- 
graph; (c) a restrictive functional respiratory pattern; 
and (d) the absence of known agents capable of 
causing interstitial pulmonary disease. All idiopathic 
pulmonary fibrosis patients had a severe alveolitis 
documented by BAL (> 10% of neutrophils) and high 
resolution computed tomography. 
Group 5 (neoplastic infiltration of the lung) 
This group comprised five women (mean age 58 
years) with pathologically proven breast adenocarci- 
noma and metastatic infiltration of the lung. In all 
cases, there was no evidence of infection due to 
opportunistic bacteria, congestive heart failure or 
other associate factors. 
Group 6 (Pneumocystis carinii pneumonia) 
This group included five HIV( +) intravenous drug 
users. All patients were men with a mean age of 29 
years. The diagnosis of P. carinii pneumonia was 
based on the demonstration of parasite by Diff- 
Quik@, Grocott and direct immunofluorescence 
stains. All patients displayed moderate hypoxaemia 
and a restrictive functional respiratory pattern. 
BRONCHOALVEOLAR LAVAGE 
Bronchoalveolar lavage (BAL) was performed as 
described (7). Transnasal fibre optic bronchoscopy 
and BAL were performed after premeditation with 
atropine and topical anaesthesia with lidocaine. 
Three 50-ml aliquots of sterile 0.9% saline solution 
were instilled and immediately withdrawn into a 
subsegmental bronchus of the right middle lobe or 
lingula. After each instillation, fluid was recovered by 
aspiration, collected in sterile polystyrene tubes and 
immediately transported, on ice, to the laboratory for 
examination. The BAL fluid obtained was quantified 
and filtered through two layers of sterile surgical 
gauze. Mean recovered volume was 60-70% of 
instilled fluid. Following this, it was centrifuged at 
500 X g for 10 min at room temperature into poly- 
styrene tubes, the cell pellet washed twice with 
phosphate-buffered saline (PBS, pH 7.4) and the cells 
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resuspended at a concentration of lo6 cells mll i. 
Cell viability, determined by Trypan blue dye ex- 
clusion was >92% in all cases. The total number of 
cells was counted in a Neubauer chamber. Using 
cytocentrifuge preparations stained with Diff-Quik 
(American Scientific, McGaw Park, IL), a conven- 
tional differential count of 200 cells was performed 
by two independent observers. The identity of 
macrophages was confirmed by non-specific esterase 
staining. Mononuclear cells were separated immedi- 
ately by centrifugation over a Ficoll-Hypaque gradi- 
ent, and after two washings were resuspended 
in sucrose-EDTA buffer (sucrose 0.25 M, EDTA 
0.002 M) and stored at - 70°C until required. Lym- 
phocytes and macrophages were not separated from 
each other for two reasons: (a) lysozyme and ECA 
enzyme content of lymphocytes is nil1 (18); and (b) 
separation methods can modify the enzymatic con- 
tent of the cells by inducing release of enzymes (9). 
Homogenates were prepared using mechanical dis- 
ruption at 0°C (Polytron Typ PT 10135 Kinematic, 
Switzerland) and three freeze-thawing cycles. Cell 
lysis was verified microscopically with Trypan blue 
dye. An aliquot was centrifuged at 800 x g for 10 min 
and the supernatant was used for enzyme assays 
(lysozyme and lysosomal hydrolases). Determination 
of angiotensin-converting enzyme was performed on 
the non-centrifuged homogenates. 
ENZYMATIC ACTIVITY MEASUREMENTS 
Angiotensin-converting enzyme catalytic activity 
was measured at 37°C by the rate of hydrolysis of 
hypurylglicylglycine (Boehringer Mannheim SA kit 
78 9011) according to the method of Lieberman (10). 
Activity was expressed in nkat per lo6 alveolar 
macrophages. Lysozyme catalytic activity was meas- 
ured kinetically at 25°C by monitoring the decrease in 
the absorbance of a Micrococcus luteus suspension at 
450 nm on a Spectronic 3000 (Bausch & Lomb) 
according to a standardized method (11). Micro- 
coccus luteus and lysozyme were purchased from 
Boehringer Mannheim (cat 107387 and cat 107255). 
Activity was expressed in nKat per lo6 alveolar 
macrophages. Acid phosphatase catalytic activity 
was measured at 37°C by a calorimetric kinetic assay 
modified by Hillman (12) using a standardized test 
(Boehringer Mannheim 287539). Activity was 
expressed in nKat per lo6 alveolar macrophages. 
P-glucuronidase catalytic activity was measured using 
a Sigma kit (no 325) based on the procedure 
described by Fishman et al. (13) modified by using 
an incubation temperature of 56°C instead of 37°C. 
Activity was expressed in Sigma units per lo6 
alveolar macrophages. Finally, p-D-N-Acetyl gluco- 
saminidase catalytic activity was measured at 37°C 
using an automated procedure according to the 
method of Iimura (14). 
All measurements were carried out on the same 
day and under the same conditions to avoid 
interassay variability. 
STATISTICAL ANALYSIS 
Data are expressed as medians f interquartilic 
range. Statistical analysis was performed using non- 
parametric tests (Kruskal-Wallis test for global 
comparison, Mann-Whitney test for two-groups 
comparison and Spearman rank correlation test) 
using the Statworks and Statview software program 
for an Apple Macintosh@ computer. For compari- 
sons, P values co.05 were adopted as significant. 
Results 
The bronchoalveolar lavage total and relative 
(expressed by relation to BALF volume) cell counts 
are shown in Table 1. Patients with allergic extrinsic 
alveolitis and P. carinii pneumonia had significantly 
increased total and relative bronchoalveolar lavage 
cell counts compared with the other groups. Differ- 
ential cells counts are shown in Table 2. The pro- 
portion of bronchoalveolar lavage lymphocytes 
was significantly elevated in the patients with active 
sarcoidosis, allergic extrinsic alveolitis and neoplasic 
infiltration as compared with the other groups. The 
proportions of bronchoalveolar lavage neutrophils 
and eosinophils were significantly elevated in the 
patients with idiopathic pulmonary fibrosis. 
All alveolar macrophage lysates displayed enzy- 
matic activity for all the enzymes studied. The mean 
specific activity of each of the groups of patients is 
shown in Figs l-3. The highest macrophage lysozyme 
activity was in the active sarcoidosis group, which 
was significantly greater than in the other groups 
(Fig. 1). Angiotensin-converting enzyme activity was 
also significantly greater in this group (Fig. 2). 
Lysosomal acid hydrolase activity was greatest in 
the group of patients with active sarcoidosis, par- 
ticularly j%glucuronidase activity and P-D-N-acetyl 
glucosaminidase activity, the mean values of which 
were 4.5- and 8-fold greater than those in the control 
group (Fig. 3). Macrophage acid phosphatase activ- 
ity was also significantly elevated in the group of 
patients with sarcoidosis, albeit to a lesser extent. 
Finally, P-glucuronidase activity was significantly 
higher in the group of patients with infiltration due to 
adenocarcinoma than in the control group (Fig. 3). 
A significant positive correlation was found 
between the percentage of lymphocytes and both 
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Table I Total and relative cell numbers in bronchoalveolar lavage fluid (BALF) 
Total cells ( x 106)* 
Cell concentrations 
( x lo6 ml-’ BALF)* 
Median IQRt 
Control (n=5) 
Unactive sarcoidosis (n=4) 
Active sarcoidosis (n = 6) 
Extrinsic allergic alveolitis (n= 5) 
Idiopathic pulmonary fibrosis (n=5) 
Neoplasic infiltration of the lung (n=5) 
Pneumocystis carinii pneumonia 
(HIV patients) (n= 5) 
15 9-16 0.20 0.13-0.37 
25 8-35 0.31 0.09-0.47 
28 8-51 0.36 0.07-0.41 
45t. 32-99 0.721 0.58-1.08 
15 7-31 0.30 0.18-0.40 
17 12-25 0.34 0.160.49 
‘3% 59-61 0.60$ 0.58-0.90 
Median IQR 
*P<O.O5 (Kruskal-Wallis test); 
tinterquartilic range (25th-75th percentile); 
$P<O.O5 compared to control group (Mann-Whitney test). 
Table 2 Differential cell counts in bronchoalveolar lavage fluid 









Control (n= 5) 
Unactive sarcoidosis (n=4) 
Active sarcoidosis (n = 6) 
Hypersensitivity pneumonitis 
(n=5) 
Idiopathic pulmonary fibrosis 
(n=5) 
Neoplasic infiltration of the lung 
(n=5) 
Pneumocystis carinii pneumonia 
(HIV patients) (n = 5) 
89 86-94 7 3-10 3 2-3 0 Ml 
741 7G-83 21 1425 1 l-2 3 l-2 
413 34-51 573 4663 1 l-2 1 o-1 
34$ 19-68 513 29-59 2 1-13 2 G-6 
543 36-65 8 5-12 291 20-50 31 3-8 
67$ 48-86 311: 12-47 1 l-3 0 O-1 
711 33-86 24 lo-39 5 2-26 2 1-2 
*P<O.O5 (Kruskal-Wallis test); 
tinterquartilic range (25th-75th percentile); 
$P<O.O5 compared to control group (Mann-Whitney test). 
alveolar macrophage angiotensin-converting enzyme 
activity (Rs=0.41; PzO.02) and lysozyme activity 
(Rs=0.43; P=O.O14), but no correlation was found 
between alveolar macrophage lysosomal activity and 
the percentage of lymphocytes. A significant negative 
correlation was found between the percentage of 
neutrophils and alveolar macrophage lysosomal 
enzyme activity [acid phosphatase (Rs= - 0.42; 
P=O.O2), P-glucuronidase (Rs= - 0.36; P=O.O4) and 
/3-D-NAGA (Rs= - 0.47; P=O.Ol)]. No significant 
correlation was observed between the percentage of 
neutrophils and either alveolar macrophage 
angiotensin-converting enzyme or lysozyme activity. 
No significant correlation was observed between 
the percentage of eosinophils and any alveolar 
macrophage enzymatic activities. Moreover, no 
significant correlation was found between total num- 
bers of non-AM cells (lymphocytes, neutrophils or 
eosinophils) and any alveolar macrophage enzymatic 
activities. 
Discussion 
Accumulation of inflammatory cells in the alveolar 
region of the lung is a key event in the pathogenesis of 
diffuse pulmonary interstitial diseases. Several soluble 
mediators released by inflammatory cells can damage 
lung tissue and lead to structural derangements of the 
lung parenchyma. The aim of the present study was 
to assess the catalytic activity of alveolar macrophage 
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Fig. 1 Lysozyme, acid phosphatase and /I-D-N-acetyl-glucuronidase activities in alveolar macrophages from diffuse 
interstitial pulmonary diseases. *Significant differences (P~0.05) in comparison with the control group. Solid bars, 
p-D-N-acetyl glucuronidases; open bar, lysozyme; stippled bar, acid phosphatase. 
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Fig. 2 Angiotensin-converting enzyme activity in alveolar macrophages from diffuse interstitial pulmonary diseases. 
*Significant differences (PcO.05) in comparison with the control group. 
hydrolases (angiotensin-converting enzyme, lysozyme striking feature was the ‘normal’ lysosomal activity 
and lysosomal acid hydrolases) in various pathogenic detected in the alveolar macrophages from patients 
types of human diffuse interstitial pulmonary dis- with allergic extrinsic alveolitis. 
eases. The highest alveolar macrophage enzymatic The results of the present work confirm previous 
activities were in the active sarcoidosis group. A observations (8) showing that human alveolar 
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Fig. 3 p-glucuronidase activity in alveolar macrophages 
differences (P~0.05) in comparison with the control group. 
macrophages display angiotensin-converting enzyme 
activity. Alveolar macrophage angiotensin- 
converting enzyme activity has mainly been related 
to the development of granulomatous lesions in the 
lung, rises having been reported in serum (15), bron- 
choalveolar lavage fluid (16) and alveolar macro- 
phages (17) of patients with sarcoidosis. The present 
work showed that the elevation of angiotensin- 
converting enzyme activity was highest in active 
sarcoidosis. There were also rises in angiotensin- 
converting activity in some cases of allergic extrinsic 
alveolitis, a disease in which granulomas are formed. 
This had previously been demonstrated indirectly 
by Larsson et al. in patients with subclinical forms of 
allergic extrinsic alveolitis (18). However, there was 
considerable intra-group variability, probably related 
to the stage of development of the disease. The 
positive correlation between angiotensin-converting 
enzyme activity and the percentage of lymphocytes 
suggests a role of lymphocyte cytokines in the induc- 
tion of the enzyme. In this sense, positive feedback 
was established between macrophage-derived 
cytokines (i.e. IL-I, IL-6) and lymphocyte-derived 
cytokines (i.e. y-IFN) in the granuloma formation 
during active sarcoidosis (19). 
Alveolar macrophages are the body cells with the 
highest lysozyme activity (20). The main biological 
activities of this protein include hydrolysis of the 
from diffuse interstitial pulmonary diseases. ,*Significant 
peptidoglucan moiety of the bacterial cell wall, fun- 
gus opsonization and modulation of the lymphocyte 
response (20). The authors have observed that in all 
types of diffuse interstitial pulmonary diseases there 
is a tendency for intramacrophage lysozyme activity 
to increase, although with strong intra-group vari- 
ability. However, lysozyme activity was significantly 
increased in the alveolar macrophages from patients 
with active sarcoidosis. This finding can explain the 
elevated serum lysozyme values observed in pulmon- 
ary sarcoidosis. The explanation for this finding is 
not obvious since it is generally considered that the 
cells of the phagocyte mononuclear system synthesize 
and release lysozyme constitutively (20) and activa- 
tion decreases the release. However, this phenom- 
enon is not completely true since, although several 
classic stimulants (phagocytosis of bacteria, phorbol- 
myristate, C5a, y-interferon) do not increase the 
production of lysozyme by alveolar macrophages, 
other agents (tobacco smoke, Calmette-Guerin bacil- 
lus, glucans and TNFa) increase synthesis, intra- 
cellular concentration and release of lysozyme (1,21). 
It is possible that antigen(s) involved in the patho- 
genesis of sarcoidosis or certain cytokines released 
by helper T-lymphocytes are responsible for this 
phenomenon. 
Lysosomal acid hydrolases form a group of 
enzymes whose function is to degrade the material 
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ingested in the phagocytic vacuole. However, lyso- 
somal enzymes can sometimes gain access to the 
extracellular medium where they exert a lytic action 
by degrading collagen and proteoglycans under acid 
pH conditions (as happens at the focus of inflamma- 
tion) (22). The results of the present study suggest 
there is an important increase in the intracellular 
activity of all the acid hydrolases studied in active 
sarcoidosis and, in the case of P-glucuronidase, also 
in the neoplasic infiltration group. Nevertheless, in 
allergic extrinsic alveolitis, and to a lesser extent in 
idiopathic pulmonary fibrosis, diseases in which 
other methods have demonstrated a strong activation 
of macrophages, the activities of the various enzymes 
were similar to those of the control group. Lysosomal 
intracellular activity depends on the equilibrium 
between their production and release into the extra- 
cellular medium. In turn, production depends on 
cellular differentiation and the degree of activation; 
levels of lysosomal hydrolases vary in different sub- 
populations of alveolar macrophages (minimum 
activity corresponding to the most immature forms) 
(23) while enzymatic activity increases upon activa- 
tion by various physical, chemical and biological 
agents (2426). The other factor affecting intracellu- 
lar acid hydrolase activity is the release of enzymes 
into the extracellular medium mediated by particu- 
late (27-29) or immunological stimuli (30,31). Taking 
into account these data, we can hypothesize that in 
active sarcoidosis, a disease in which alveolar macro- 
phages are activated by lymphocyte cytokines, there 
is a rise in the synthesis of lysosomal enzymes but no 
marked extracellular release, whereas in allergic 
extrinsic alveolitis and idiopathic pulmonary fibrosis 
the presence of particulate antigens and/or immune 
complexes would lead to an increase in the release of 
enzymes into the alveolar region. This interpretation 
is sustained by experimental data obtained by the 
authors in guinea pigs (32). Increased acid hydrolases 
lysosomal release might contribute to inflammation 
found in these diseases. Alternatively, increased 
release of these enzymes may serve as a marker for 
concurrent secretion of a variety of macrophage 
factors capable of causing lung injury or recruitment 
of inflammatory cells. The negative correlation found 
between intracellular acid hydrolases activities and 
BAL percentage of neutrophils mainly suggest the 
later interpretation. 
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